TP-05 is under clinical development by Tarsus Pharmaceuticals and currently in Phase II for Lyme Disease. According to GlobalData, Phase II drugs for Lyme Disease have an 80% phase transition success ...

An uptick in reported cases of Lyme disease since 2022 may have many factors, but one contributing factor may be the lengthening of tick season due to warmer temperatures appearing earlier in the ...

( BDN) -- Maine saw a record-breaking number of tick-borne disease cases in 2024 for a second year in a row. Between January ...

Data from the Maine CDC show that the rate of tickborne diseases was especially high among Mainers in the midcoast. Ticks ...

Alpha-gal syndrome, a tick-borne illness, is shaping up to be the new Lyme disease. Learn more about the disease and why it ...

An additional 128 (54%) could not be assigned a specific diagnosis or category using the current CDC surveillance criteria for Lyme disease and had medically unexplained symptoms. Among the ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

Given the risks, it is impossible to argue that prolonged iv. antibiotics are ethically justified for patients with post-Lyme disease syndromes. These same risks naturally apply to other ...

Wegovy and Ozempic are the exact same drug: semaglutide. They are dosed slightly differently and marketed for different ...

A man from Wiltshire is part of a team rowing across the Atlantic Ocean and has shared how they capsized during bad weather.  | ITV News ...

You've heard of Lyme disease, but there's a relatively new tick-borne illness in town, and its symptoms have been leaving ...

I’m wondering if any studies explain this and what’s the best way to address it. Should I increase the dose further or switch ...